Literature DB >> 29518759

Surgery for pheochromocytoma: A 20-year experience of a single institution.

Chrysanthi Aggeli1, Alexander M Nixon1, Christos Parianos1, Georgios Vletsis1, Labrini Papanastasiou2, Athina Markou2, Theodora Kounadi2, Georgrios Piaditis2, Georgios N Zografos3.   

Abstract

OBJECTIVE: Resection of pheochromocytomas is a challenging procedure due to hemodynamic lability. Our aim was to evaluate surgical outcomes in 67 patients with pheochromocytoma and to validate the role of laparoscopic surgery in the treatment of these tumors.
DESIGN: This study is a retrospective review. A total of 68 procedures for pheochromocytoma were performed between June 1997 and February 2017. All patients were investigated and operated on using an established departmental protocol. Relevant data were retrieved from the hospital records of 533 patients who underwent 541 adrenalectomies for benign and malignant adrenal tumors in the same period.
RESULTS: Sixty-nine tumors were removed from 67 patients. One patient with/MEN2A underwent bilateral resection of pheochromocytomas in two stages. Tumor size in laparoscopic procedures ranged from 1.2 cm to 11.0 cm (mean 5.87 cm). Thirty-seven patients had benign disease, 31 potentially malignant (based on PASS) and 1 malignant with metastasis. Eight were in the context of a familial syndrome. Forty-nine patients underwent laparoscopic adrenalectomy, 8 patients had open approach from the start for recurrent pheochromocytoma or large benign tumor, 1 patient had open approach due to inoperable malignant pheochromocytoma and 10 patients had conversions from laparoscopic to open procedure. Nine patients received sodium nitroprusside intraoperatively to treat hypertension. One patient developed pulmonary embolism and succumbed 1 month later. There were no recurrences of the benign or potentially malignant tumors during the follow-up period.
CONCLUSIONS: Laparoscopic resection of pheochromocytomas, despite its increased level of difficulty compared to that of other adrenal tumors, is a safe and effective procedure.

Entities:  

Mesh:

Year:  2017        PMID: 29518759     DOI: 10.14310/horm.2002.1759

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  5 in total

1.  Resection of Pulmonary Metastases 12 Years after Initial Surgery for a Benign Pheochromocytoma.

Authors:  Michiko Ueda; Fumihiro Shoji; Yuka Kozuma; Gouji Toyokawa; Koji Yamazaki; Seiya Momosaki; Sadanori Takeo
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-10-16       Impact factor: 1.889

2.  Haemorrhage in pre-existing adrenal masses. A case series.

Authors:  Alexander M Nixon; Anna Botou; Chrysanthi Aggeli; Evaggelos Falidas; Theodosia Choreftaki; Georgios N Zografos
Journal:  Int J Surg Case Rep       Date:  2020-04-02

3.  An Analysis of Computed Tomography Imaging Features and Predictive Factors for Postoperative Recurrence and Metastasis of Abdominal Paragangliomas.

Authors:  Bailing Dai; Jie He; Xiandi Zhu; Zongyu Xie; Cui Zhang; Xiaoli Zhou; Zhao Yang; Jian Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-02-21       Impact factor: 3.161

4.  Adrenal bleeding due to pheochromocytoma - A call for algorithm.

Authors:  Ewelina Rzepka; Joanna Kokoszka; Anna Grochowska; Magdalena Ulatowska-Białas; Martyna Lech; Marta Opalińska; Elwira Przybylik-Mazurek; Aleksandra Gilis-Januszewska; Alicja Hubalewska-Dydejczyk
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

5.  Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience.

Authors:  Liang Zhang; Danlei Chen; Yingxian Pang; Xiao Guan; Xiaowen Xu; Cikui Wang; Qiao Xiao; Longfei Liu
Journal:  Asian J Urol       Date:  2022-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.